BA
ARIA

BlackRock Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

BlackRock Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.44M Sell
196,087
-12,820
-6% -$154K ﹤0.01% 1416
2016
Q3 		$2.86M Buy
208,907
+29,045
+16% +$292K ﹤0.01% 1335
2016
Q2 		$1.33M Buy
179,862
+31,123
+21% +$234K ﹤0.01% 1644
2016
Q1 		$950K Buy
148,739
+5,981
+4% +$33.5K ﹤0.01% 1765
2015
Q4 		$892K Sell
142,758
-21,390
-13% -$140K ﹤0.01% 1770
2015
Q3 		$959K Sell
164,148
-285,506
-63% -$2.2M ﹤0.01% 1722
2015
Q2 		$3.72M Buy
449,654
+209,090
+87% +$1.85M ﹤0.01% 1072
2015
Q1 		$1.98M Buy
240,564
+146,460
+156% +$1.08M ﹤0.01% 1233
2014
Q4 		$646K Sell
94,104
-4,707
-5% -$29.4K ﹤0.01% 1799
2014
Q3 		$534K Sell
98,811
-40,328
-29% -$236K ﹤0.01% 1914
2014
Q2 		$886K Buy
139,139
+106,681
+329% +$734K ﹤0.01% 1587
2014
Q1 		$262K Hold
32,458
– – ﹤0.01% 2498
2013
Q4 		$221K Sell
32,458
-1,957,385
-98% -$10.6M ﹤0.01% 2601
2013
Q3 		$36.6M Buy
1,989,843
+1,602,677
+414% +$31.1M 0.04% 396
2013
Q2 		$6.77M Buy
+387,166
New +$6.86M 0.01% 876

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

BlackRock Advisors's ARIA Position: Q4 2016 in Review

BlackRock Advisors reduced its Ariad Pharmaceuticals Inc (ARIA) stake by 6.1% in Q4 2016, selling an estimated $154K and leaving 196,087 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

BlackRock Advisors first reported a position in ARIA in Q2 2013 and has held it in 15 quarters since. The position peaked at $36.6M in Q3 2013. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

  • BlackRock Advisors held 196,087 shares of Ariad Pharmaceuticals Inc worth $2.44M as of Q4 2016.
  • BlackRock Advisors sold 12,820 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $154K.
  • Ariad Pharmaceuticals Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1416 holding.
  • BlackRock Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Ariad Pharmaceuticals Inc position peaked at $36.6M in Q3 2013.
  • 200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.